We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.88%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$56.7B
AUM Growth
+$8.88B
(+19%)
Cap. Flow
+$7.92B
Cap. Flow
% of AUM
13.98%
Top 10 Holdings %
Top 10 Hldgs %
34.05%
Holding
2,107
New
102
Increased
1,467
Reduced
463
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$779M |
| 2 |
Apple
AAPL
|
+$539M |
| 3 |
Microsoft
MSFT
|
+$522M |
| 4 |
Meta Platforms (Facebook)
META
|
+$487M |
| 5 |
Tesla
TSLA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$189M |
| 2 |
C.H. Robinson
CHRW
|
+$55.4M |
| 3 |
Fortinet
FTNT
|
+$55M |
| 4 |
AbbVie
ABBV
|
+$35.7M |
| 5 |
NextEra Energy
NEE
|
+$32.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.38% |
| 2 | Communication Services | 10.74% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Industrials | 8.58% |
| 5 | Consumer Staples | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
argenx
ARGX
$52B
| $1.08M | ﹤0.01% |
1,286
+195
| +18% | +$167K |
|
802
Applied Digital
APLD
$9B
| $1.08M | ﹤0.01% |
44,078
+7,426
| +20% | +$214K |
|
803
CNX Resources
CNX
$5.33B
| $1.08M | ﹤0.01% |
29,254
-166
| -0.6% | -$5.95K |
|
804
CRISPR Therapeutics
CRSP
$4.88B
| $1.07M | ﹤0.01% |
20,447
+2,594
| +15% | +$155K |
|
805
iRhythm Holdings
IRTC
$4.1B
| $1.05M | ﹤0.01% |
5,944
+490
| +9% | +$86.8K |
|
806
Boot Barn
BOOT
$4.8B
| $1.05M | ﹤0.01% |
5,972
+175
| +3% | +$32.6K |
|
807
Kymera Therapeutics
KYMR
$8.25B
| $1.05M | ﹤0.01% |
13,489
+2,320
| +21% | +$157K |
|
808
Cirrus Logic
CRUS
$6.42B
| $1.05M | ﹤0.01% |
8,852
+1,658
| +23% | +$204K |
|
809
Lumentum
LITE
$66.1B
| $1.05M | ﹤0.01% |
2,844
-125
| -4% | -$32.1K |
|
810
Roivant Sciences
ROIV
$24.1B
| $1.05M | ﹤0.01% |
48,290
+5,664
| +13% | +$112K |
|
811
Indivior Pharmaceuticals
INDV
$4.42B
| $1.05M | ﹤0.01% |
29,139
+3,949
| +16% | +$121K |
|
812
Uranium Energy
UEC
$5.2B
| $1.02M | ﹤0.01% |
87,224
+14,384
| +20% | +$189K |
|
813
Belden
BDC
$4.8B
| $1.02M | ﹤0.01% |
8,736
+274
| +3% | +$32K |
|
814
ADMA Biologics
ADMA
$2.07B
| $1.02M | ﹤0.01% |
55,655
+3,362
| +6% | +$56.7K |
|
815
Sabra Healthcare REIT
SBRA
$5.2B
| $1.01M | ﹤0.01% |
53,483
+2,604
| +5% | +$48.3K |
|
816
Merit Medical Systems
MMSI
$5.11B
| $1M | ﹤0.01% |
11,383
+351
| +3% | +$29.9K |
|
817
Mohawk Industries
MHK
$9.01B
| $993K | ﹤0.01% |
9,088
-213
| -2% | -$24.5K |
|
818
Lantheus
LNTH
$6.59B
| $992K | ﹤0.01% |
14,911
+355
| +2% | +$20.7K |
|
819
Moelis & Co
MC
$5.08B
| $992K | ﹤0.01% |
14,435
+430
| +3% | +$28.7K |
|
820
Main Street Capital
MAIN
$5.31B
| $991K | ﹤0.01% |
16,412
-1,560
| -9% | -$92K |
|
821
Exelixis
EXEL
$13.8B
| $990K | ﹤0.01% |
22,592
+1,551
| +7% | +$64.2K |
|
822
ESCO Technologies
ESE
$8.24B
| $988K | ﹤0.01% |
5,055
+157
| +3% | +$33.1K |
|
823
Granite Construction
GVA
$5.43B
| $981K | ﹤0.01% |
8,501
+251
| +3% | +$27K |
|
824
Crinetics Pharmaceuticals
CRNX
$8.89B
| $965K | ﹤0.01% |
20,721
+1,917
| +10% | +$85.3K |
|
825
BioMarin Pharmaceuticals
BMRN
$11.6B
| $961K | ﹤0.01% |
16,177
+1,170
| +8% | +$63.7K |
|
Similar funds
ProShare Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, ProShare Advisors held 2,107 positions worth $56.7B, up 19% from $47.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
ProShare Advisors deployed $7.92B of net new capital in Q4 2025, opening 102 new positions and adding to 1,467 existing holdings. Its largest new stake was CRH: 131,018 shares worth $16.4M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Broadcom, an estimated $189M trimmed.
- ProShare Advisors's largest Q4 2025 buy was CRH: 131,018 shares worth $16.4M.
- ProShare Advisors added most to NVIDIA in Q4 2025, an estimated $779M increase.
- ProShare Advisors's biggest Q4 2025 reduction was Broadcom, cutting an estimated $189M.
- ProShare Advisors fully exited Perrigo in Q4 2025, selling an estimated $27.6M.
- ProShare Advisors's ten largest holdings make up 34% of its $56.7B portfolio in Q4 2025.
- ProShare Advisors opened 102 new positions and closed 73 in Q4 2025.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $56.7B.
Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.